- Home
- Personal stories
Personal stories
Care in action: Empowering community health workers to address TB underdiagnosis
J&J CareCommunity is empowering communities to address one of the most significant barriers to ending tuberculosis (TB): underdiagnosis.
Measuring what matters: The evolving role of impact measurement and management
Samatha Curtis from The Good Economy shares four recommendations for impact investors.
Using your own cells to fight cancer
Cell therapy is bringing the world one step closer to eliminating cancer. Here’s how Johnson & Johnson is moving this cutting-edge therapy forward.
J&J Impact Ventures invests in Rology to expand access to critical, high-quality radiology diagnostics
By advancing innovative teleradiology solutions, more patients receive the critical imaging interpretations they need—when and where they need them most.
Bridging the Gap: New J&J CareCommunity collaborations support 70,000 health workers across Latin America
By investing in health workers and local infrastructure, J&J CareCommunity is helping strengthen communities and expand access to care across Latin America.
Accelerating impact: The acquisition of CareAcademy by Activated Insights
With the acquisition, more health workers across the U.S. will be able to access a comprehensive learning platform to develop new skills.
Moving toward a more personalized approach to treating depression
The World Health Organization predicts that depression will be the leading cause of disability across the globe by 2030. Learn how Johnson & Johnson is on a mission to change that.
“Our goal is a solution for every bladder cancer patient”
Meet Christopher Cutie, M.D., the Johnson & Johnson scientist who’s helping change the treatment landscape for people with bladder cancer, the tenth most common cancer in the world.
J&J Impact Ventures invests in ThinkMD, increasing the availability and accuracy of clinical decision-making at the point of care
What if any healthcare worker—regardless of training, tenure or location—could be empowered with adaptive tools that enable them to conduct high-quality clinical assessments?